first
pandem
twenti
first
centuri
outbreak
sever
acut
respiratori
syndrom
sar
caus
sarscov
coronaviru
far
known
outbreak
due
deliber
releas
sarscov
coronaviru
rather
natur
occur
event
appear
sar
seem
involv
zoonot
origin
sarscov
eg
horsesho
bat
andor
chiroptera
one
wildlif
reservoir
jani
et
al
transmiss
intermedi
host
eg
civet
cat
racoon
dog
feng
gao
human
contact
intermedi
host
southern
china
guangdong
provinc
novemb
subsequ
crossspeci
transmiss
coronaviru
human
feng
gao
transmiss
viru
nonhospit
person
contact
hospit
staff
contact
zhang
global
transmiss
viru
via
travel
affect
region
asia
countri
sar
eventu
control
increas
hygien
measur
eg
face
mask
protect
frequent
hand
wash
live
quarter
disinfect
travel
restrict
quarantin
implic
emerg
spread
sar
omin
new
viru
emerg
identifi
previous
due
combin
sever
factor
includ
gestat
period
outbreak
identifi
caus
viru
discov
bureaucrat
delay
report
extent
pandem
chines
offici
insuffici
initi
hygien
measur
inadequ
hospit
capac
deal
full
extent
treatment
confin
insuffici
initi
travel
commun
restrict
sar
spread
thirti
countri
final
contain
outbreak
case
report
world
health
organ
case
fatal
rate
approxim
hao
et
al
would
number
chang
sarscov
deliber
releas
bioterrorist
advanc
technolog
would
requir
infect
intermedi
host
could
distribut
multipl
locat
serv
multipl
sourc
infect
time
intent
natur
outbreak
recogn
would
spread
global
caus
overwhelm
strain
healthcar
resourc
throughout
world
one
less
tangibl
weapon
arsen
combat
bioterror
natur
pandem
intellig
myriad
form
includ
direct
use
human
access
inform
use
sophist
comput
system
track
infrastructur
resourc
movement
use
literaturerel
discoveri
techniqu
help
predict
develop
engin
biolog
threat
agent
swanson
et
al
predict
emerg
natur
occur
pathogen
develop
technolog
detect
neutral
shield
vaccin
biowarfar
natur
occur
agent
demonstr
use
text
mine
gain
better
understand
sar
sarscov
inform
could
use
impact
prepared
respons
activ
threepart
examin
global
sar
literatur
undertaken
first
part
global
sar
research
literatur
retriev
infrastructur
literatur
key
research
institut
journal
etc
medic
structur
medic
theme
interrelationship
among
theme
identifi
second
part
semin
document
literatur
identifi
summar
histor
literatur
review
eg
kostoff
et
al
third
part
literaturerel
discoveri
kostoff
kostoff
et
al
use
identifi
potenti
prevent
measur
treatment
sar
scienc
technolog
comput
linguist
hearst
losiewicz
et
al
process
underli
extract
use
inform
larg
volum
technic
text
identifi
pervas
technic
theme
larg
databas
technic
phrase
occur
frequent
also
identifi
relationship
among
theme
group
cluster
phrase
parent
document
basi
similar
comput
linguist
use
number
purpos
includ
enhanc
inform
retriev
increas
awar
global
technic
literatur
kostoff
et
al
greengrass
discoveri
innov
base
merg
common
linkag
among
dispar
literatur
swanson
kostoff
kostoff
et
al
uncov
unexpect
asymmetri
technic
literatur
goldman
et
al
kostoff
estim
global
level
effort
subdisciplin
kostoff
et
al
help
author
increas
citat
statist
improv
access
publish
paper
also
may
help
journal
increas
impact
factor
kostoff
et
al
b
track
impact
specif
research
area
across
time
applic
area
davids
van
raan
kostoff
et
al
evalu
bibliometr
narin
garfield
schubert
et
al
use
count
public
patent
citat
potenti
inform
item
develop
perform
indic
valid
base
premis
count
patent
paper
valid
indic
r
activ
subject
area
patent
paper
number
time
patent
paper
cite
subsequ
patent
paper
valid
indic
import
impact
cite
patent
paper
citat
paper
paper
patent
patent
patent
paper
indic
intellectu
linkag
organ
produc
patent
paper
knowledg
linkag
subject
area
narin
et
al
evalu
bibliometr
use
identifi
infrastructur
author
journal
institut
technic
domain
identifi
expert
innovationenhanc
technic
workshop
review
panel
develop
site
visit
strategi
assess
prolif
organ
global
identifi
impact
literatur
citat
individu
research
unit
organ
countri
typic
text
mine
studi
publish
literatur
involv
develop
queri
comprehens
inform
retriev
search
databas
use
comput
linguist
bibliometr
integr
process
inform
primari
object
studi
identifi
global
research
literatur
relat
directli
sar
secondari
object
estim
rel
level
global
effort
subcategori
sar
research
reflect
emphasi
publish
literatur
citat
bibliometr
import
tool
sci
select
databas
analys
addit
record
classifi
articl
review
sci
download
sourc
databas
select
iter
search
approach
simul
nucleat
kostoff
et
al
use
gener
final
search
queri
sar
research
literatur
defin
author
studi
consist
publish
openliteratur
paper
focu
theoret
laboratori
biolog
clinic
epidemiolog
aspect
sar
coronaviru
emphas
origin
research
literatur
access
sci
sar
literatur
defin
oper
follow
queri
sar
coronaviru
infect
viru
viral
epidem
epidemiolog
antibodi
antibodi
vaccin
influenza
pandem
outbreak
syndrom
sar
patient
sar
transmiss
sarscov
sever
acut
respiratori
syndrom
base
recent
text
mine
result
kostoff
et
al
document
cluster
theme
identif
method
use
perform
use
abstract
text
document
cluster
combin
document
group
base
text
similar
document
cluster
provid
number
document
cluster
proxi
metric
level
emphasi
taxonomi
categori
approach
use
studi
base
partit
cluster
algorithm
karypi
zhao
karypi
contain
within
softwar
packag
name
cluto
figur
show
number
sar
sci
articl
retriev
queri
function
time
total
paper
retriev
major
countri
produc
sar
research
articl
tempor
product
follow
countrynumb
sci
articl
china
usa
canada
singapor
china
usa
taiwan
canada
china
usa
canada
taiwan
distribut
reflect
countri
hit
hardest
sar
china
singapor
taiwan
canada
role
usa
lead
public
health
respons
furthermor
tempor
pattern
observ
reflect
emerg
previous
unrecogn
diseas
discoveri
caus
agent
controlelimin
diseas
prolif
sar
research
author
sinc
first
paper
publish
public
frequenc
shown
tabl
author
list
collabor
paper
shown
fig
last
column
tabl
reflect
number
paper
author
list
doublecount
involv
five
author
yuen
pieri
k
h
chan
p
k
chan
sung
account
total
number
articl
n
publish
top
prolif
sar
research
author
nine
prolif
author
china
hong
kong
tenth
japan
one
author
research
institut
nine
univers
identifi
author
associ
highli
cite
sar
paper
frequent
cite
sarsrel
document
list
sci
retriev
author
frequenc
extract
top
central
author
shown
tabl
five
author
appear
list
prolif
sar
research
author
tabl
tabl
doublecount
due
coauthorship
citat
data
author
journal
repres
citat
gener
specif
record
extract
sci
databas
studi
data
repres
citat
receiv
paper
record
could
receiv
addit
citat
paper
technic
disciplin
seven
author
china
two
netherland
one
usa
best
perform
chines
author
absolut
term
rel
cite
paper
studi
seen
visual
way
display
collabor
team
indic
coauthorship
autocorrel
map
autocorrel
function
describ
correl
random
function
copi
shift
lag
distanc
autocorrel
map
author
show
team
peopl
publish
togeth
author
repres
map
node
relat
connect
line
differ
thick
thicker
stronger
figur
depict
author
autocorrel
map
prolif
author
ten
list
tabl
six
publish
group
evid
largest
group
yuen
guan
et
al
center
around
univers
hong
kong
second
largest
group
ii
chan
tam
wu
et
al
center
around
chines
univers
hong
kong
third
largest
group
iii
chen
chen
shen
et
al
center
around
chines
academi
scienc
fourth
largest
group
iv
cinatl
doerr
preiser
et
al
univers
frankfurt
klinikum
fifth
largest
group
v
shen
lim
hong
tan
center
around
institut
molecular
cellular
biolog
singapor
sixth
largest
group
vi
zhang
zhou
et
al
china
usa
intraconnect
within
group
vi
great
deal
interconnect
across
group
evid
diagram
base
threshold
valu
necessari
display
linkag
nine
journal
contain
sar
research
paper
list
tabl
along
number
sarsrel
paper
publish
nine
journal
contain
total
retriev
articl
two
journal
journal
virolog
emerg
infecti
diseas
clearli
constitut
first
tier
sarspublish
journal
mani
journal
highli
special
appear
quit
appli
biomed
emphas
journal
medicin
mainli
infecti
diseas
virolog
microbiolog
top
journal
cite
sar
paper
publish
list
tabl
seventysix
highli
cite
sar
paper
publish
major
medic
multidisciplinari
journal
list
tabl
journal
publish
two
highli
cite
paper
institut
produc
highest
number
sar
research
paper
recov
search
list
tabl
paper
tabl
repres
total
paper
howev
includ
doublecount
institut
coauthorship
six
top
institut
univers
three
government
one
hospit
four
china
two
usa
two
singapor
one
canada
one
taiwan
five
institut
stand
term
product
univers
hong
kong
incl
queen
mari
hospit
chines
univers
hong
kong
incl
princ
wale
hospit
chines
academi
scienc
institut
cdc
public
health
agencyinclud
variant
nation
taiwan
univers
incl
ntu
hospit
institut
produc
highli
cite
sar
paper
list
tabl
tabl
hicit
number
highli
cite
sar
paper
publish
institut
rec
total
number
sar
paper
publish
institut
two
hong
kong
institut
perform
well
term
absolut
number
highli
cite
paper
normal
total
paper
product
well
behind
european
institut
erasmu
medic
center
univers
frankfurt
behind
american
institut
harvard
univers
nih
well
countri
produc
sar
research
paper
list
tabl
number
reflect
countri
appear
paper
could
includ
doublecount
due
countri
coauthorship
except
taiwan
australia
eight
top
countri
particip
multicent
sar
collabor
access
specimen
viru
sar
patient
first
five
countri
affect
sar
outbreak
although
differ
degre
countri
produc
highli
cite
sar
paper
list
tabl
top
eight
countri
part
collabor
sar
network
countri
immedi
access
specimen
viru
sar
patient
ten
highli
cite
paper
list
tabl
interest
top
articl
publish
reflect
fact
sar
recogn
octob
paper
group
sever
broad
categori
first
identif
novel
coronaviru
associ
sar
properti
paper
ksiazek
drosten
rota
peiri
marra
second
group
paper
describ
clinic
featur
sar
paper
lee
peiri
poutanen
tsang
third
group
compris
one
paper
describ
viral
featur
could
exploit
develop
antivir
drug
paper
li
like
high
number
cite
top
five
articl
reflect
fact
cite
introduct
sar
paper
tabl
display
first
three
level
hierarch
taxonomi
retriev
sar
literatur
first
taxonomi
level
n
record
abstract
subdivid
two
categori
sar
epidemiologyclin
medicin
n
record
sar
biolog
n
record
sar
epidemiologyclin
medicin
categori
focus
control
spread
infect
treatment
facil
larger
local
global
popul
well
clinic
diagnosi
treatment
sar
sar
biolog
categori
focus
identifi
determin
structur
sar
coronaviru
identifi
mechan
develop
drug
inhibit
replic
sar
coronaviru
boundari
two
categori
rel
sharp
reflect
qualiti
cluster
approach
use
second
level
taxonomi
first
level
categori
divid
two
subcategori
sar
epidemiologyclin
medicin
divid
sar
epidemiolog
n
record
sar
diagnosi
clinic
treatment
n
record
sar
biolog
divid
sar
coronaviru
structur
n
record
sar
drug
develop
n
record
sar
epidemiolog
categori
focus
control
spread
infect
health
care
facil
well
larger
local
global
set
sar
diagnosi
clinic
treatment
categori
focus
clinic
diagnosi
treatment
sar
sar
coronaviru
structur
categori
focus
determin
structur
sar
coronaviru
sar
drug
develop
categori
focus
develop
drug
inhibit
replic
sar
coronaviru
second
level
categori
subdivid
form
eightthird
level
categori
final
level
discuss
third
level
treat
flat
taxonomi
categori
head
bold
ital
follow
categori
summari
metric
prolif
author
countri
institut
follow
compon
cluster
theme
bullet
first
four
level
categori
level
sar
epidemiologyclin
medicin
categori
categori
global
epidem
control
n
record
countri
usa
peopl
r
china
canada
england
institut
univ
hong
kong
ctr
di
control
prevent
chines
univ
hong
kong
univ
london
imperi
coll
sci
technol
med
univ
british
columbia
chines
acad
sci
emerg
infecti
diseas
n
record
pandem
influenza
n
record
public
health
monitor
n
record
sar
quarantin
n
record
model
sar
epidemiolog
n
record
categori
hospit
epidem
control
n
record
countri
peopl
r
china
usa
canada
taiwan
singapor
institut
chines
univ
hong
kong
univ
hong
kong
univ
toronto
sar
hospit
airborn
transmiss
n
record
sar
hospit
infect
control
n
record
sar
health
care
worker
protect
n
record
sar
nurs
impact
n
record
psycholog
respons
sar
n
record
categori
clinic
treatment
n
record
countri
peopl
r
china
taiwan
usa
singapor
canada
institut
chines
univ
hong
kong
univ
hong
kong
princess
margaret
hosp
sar
clinic
outcom
n
record
sar
clinic
featur
diagnosi
n
record
categori
clinic
diagnosi
n
record
countri
peopl
r
china
singapor
taiwan
canada
usa
institut
chines
univ
hong
kong
univ
hong
kong
tan
tock
seng
hosp
princess
margaret
hosp
chest
radiograph
n
record
sar
pulmonari
patholog
n
record
last
four
level
categori
level
sar
biolog
categori
categori
coronaviru
genet
compon
n
record
countri
peopl
r
china
usa
germani
netherland
canada
institut
univ
hong
kong
chines
acad
sci
chines
univ
hong
kong
ctr
di
control
prevent
sar
interferon
treatment
n
record
sar
lung
patholog
n
record
sar
coronaviru
detect
use
pcr
n
record
human
coronaviru
n
record
sar
coronaviru
natur
reservoir
n
record
genom
sequenc
sar
coronaviru
n
record
rna
viru
n
record
categori
coronaviru
protein
compon
antibodi
n
record
countri
peopl
r
china
usa
singapor
taiwan
japan
institut
chines
acad
sci
univ
hong
kong
niaid
inst
mol
cell
biol
harvard
univ
sar
coronaviru
vaccin
n
record
sar
coronaviru
nucleocapsid
protein
epitop
n
record
sar
coronaviru
antibodi
detect
n
record
sar
coronaviru
protein
structur
n
record
sar
coronavirusinduc
vero
cell
apoptosi
n
record
angiotensinconvert
enzym
sarscov
receptor
n
record
sarscov
spike
protein
fusion
peptid
n
record
categori
proteaseproteinas
inhibitor
n
record
countri
peopl
r
china
usa
taiwan
canada
germani
institut
chines
acad
sci
acad
sinica
univ
british
columbia
peke
univ
natl
taiwan
univ
sar
coronaviru
proteinas
inhibitor
n
record
sar
coronaviru
main
proteinas
pro
n
record
categori
viral
inhibit
drug
n
record
countri
usa
peopl
r
china
taiwan
belgium
japan
itali
germani
institut
univ
hong
kong
katholiek
univ
leuven
acad
sinica
tianjin
normal
univ
gordon
life
sci
inst
categori
epidemiologyrel
categori
focus
broader
epidemiolog
issu
class
emerg
infecti
diseas
surveil
monitor
quarantin
outbreak
model
epidemiolog
dynam
overal
china
produc
paper
usa
howev
categori
usa
outproduc
china
canada
overal
paper
china
half
chines
paper
categori
also
overal
chines
univers
hong
kong
almost
mani
paper
univers
hong
kong
categori
half
mani
categori
focus
attempt
control
spread
infect
within
health
care
set
identifi
effect
sar
physic
mental
health
care
giver
categori
unlik
categori
china
twice
mani
paper
usa
perhap
reflect
urgenc
much
oper
experi
sar
rel
usa
also
case
chines
univers
hong
kong
almost
paper
univers
hong
kong
categori
reflect
clinic
aspect
sar
categori
address
clinic
treatment
emphas
outcom
clinic
featur
categori
china
outproduc
usa
factor
four
reflect
much
extens
experi
treat
patient
sar
categori
address
clinic
diagnosi
emphas
chest
radiograph
pulmonari
patholog
china
outproduc
usa
factor
six
reflect
greater
experi
number
record
categori
rel
small
chines
univers
hong
kong
outproduc
univers
hong
kong
almost
factor
two
categori
reflect
variou
aspect
sar
coronaviru
pathogenesi
categori
rel
broad
address
genet
compon
coronaviru
well
structur
compon
strike
featur
categori
univers
hong
kong
doubl
paper
output
chines
univers
hong
kong
categori
reflect
protein
compon
sar
coronaviru
role
pathogenesi
host
immun
respons
potenti
vaccin
candid
chines
academi
scienc
paper
univers
hong
kong
chines
univers
hong
kong
even
among
top
five
produc
categori
reflect
issu
relat
drug
develop
categori
address
proteaseproteinas
inhibitor
hong
kong
univers
even
show
among
first
five
leader
chines
academi
scienc
follow
academica
sinica
categori
address
viru
inhibit
drug
categori
belgium
slightli
china
paper
overal
onethird
china
paper
product
main
belgian
institut
cathol
univers
louvain
summar
chines
univers
hong
kong
play
strongest
role
patient
care
epidemiolog
issu
univers
hong
kong
chines
academi
scienc
play
lead
role
biolog
research
output
among
usa
institut
cdc
play
strong
role
epidemiolog
sar
character
sar
coronaviru
niaid
harvard
play
import
role
elucid
role
viral
protein
immun
respons
potenti
vaccin
candid
sar
first
major
pandem
twenti
first
centuri
nation
involv
essenti
caught
unprepar
sinc
effort
devot
predict
new
pathogen
form
biowarfar
agent
emerg
infecti
diseas
swanson
et
al
nevertheless
multilater
collabor
rapidli
establish
exemplifi
whoorgan
multicent
collabor
network
literatur
bibliometr
result
show
prc
play
major
role
aspect
diagnos
treat
research
diseas
fact
prc
higher
fraction
highli
cite
paper
studi
seen
within
prc
research
hong
kong
institut
play
major
role
signific
advanc
across
sar
spectrum
accord
recent
survey
none
treatment
use
pandem
effect
peopl
report
contract
sar
die
given
larg
number
contact
far
peopl
contract
sar
even
though
ten
percent
die
surviv
given
lack
effect
treatment
believ
messag
fact
number
substanti
larger
use
result
third
part
studi
identifi
potenti
discoveri
treatment
prevent
relat
sar
